# 21 CFR Part 11 Conformance — drug-library-manager

> _Demo sample data — not for clinical use._

Conformance artifacts for 21 CFR Part 11 (electronic records / electronic signatures) applied to the Drug Library Manager. DLM's rule-authoring workflow (D2) and audit log (D6) are the Part 11 surfaces referenced from the PCA composition manifest.

## Expected Content

- `part-11-assessment.md` — applicability decision per Part 11 scope, predicate rule mapping (Part 11 §11.10, §11.30, §11.50, §11.70, §11.100, §11.200, §11.300)
- `electronic-signature-spec.md` — signing workflow, user authentication, signature manifestation, signer identity + date/time capture
- `audit-log-spec.md` — what's logged, retention policy, tamper-evident storage, replay mechanism
- `validation-evidence.md` — tests that prove the system meets each Part 11 predicate
- `formal/` — controlled deliverables for submission

## Conventions

- **Naming**: kebab-case filenames. Each Part 11 predicate cited verbatim in the assessment is tagged inline.
- Validation evidence cross-references the V&V artifacts (`design-controls/vnv/`) — Part 11 tests are not duplicated, they're labeled.
- Linked to: 21 CFR Part 11, FDA Computer Software Assurance guidance, IEC 62304 Class C verification requirements.

## Changelog

| Date | Author | Summary |
|------|--------|---------|
| 2026-04-20 | Ben Xavier | Stub folder — created under task 018 so the 510(k) composition manifest's Part 11 piece resolves. Awaiting content. |
